Heritage Wealth Advisors Gilead Sciences, Inc. Transaction History

Heritage Wealth Advisors

$2.16 Billion
Q2 2024

A detailed history of Heritage Wealth Advisors transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Heritage Wealth Advisors holds 2,314 shares of GILD stock, worth $203,817. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,314

Previous 2,464 6.09%

Holding current value

$203,817

Previous $180,000 12.22%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$63.15 - $72.88 $9,472 - $10,932	-150 Reduced 6.09%	2,314 $158,000
Q1 2024 May 08, 2024	SELL	$71.58 - $87.29 $6,012 - $7,332	-84 Reduced 3.3%	2,464 $180,000
Q4 2023 Feb 09, 2024	BUY	$73.27 - $83.09 $6,154 - $6,979	84 Added 3.41%	2,548 $206,000
Q2 2022 Aug 04, 2022	BUY	$57.72 - $65.01 $37,518 - $42,256	650 Added 35.83%	2,464 $152,000
Q3 2021 Nov 02, 2021	BUY	$67.69 - $73.03 $67,690 - $73,030	1,000 Added 122.85%	1,814 $126,000
Q4 2020 Feb 01, 2021	BUY	$56.65 - $64.55 $46,113 - $52,543	814 New	814 $47,000
Q3 2020 Nov 03, 2020	SELL	$62.1 - $78.08 $8,073 - $10,150	-130 Closed	0 $0
Q2 2020 Jul 17, 2020	SELL	$72.34 - $84.0 $520,848 - $604,800	-7,200 Reduced 98.23%	130 $10,000
Q2 2020 Jul 17, 2020	BUY	$72.34 - $84.0 $528,443 - $613,620	7,305 Added 29220.0%	7,330 $10,000
Q1 2020 May 05, 2020	BUY	$62.63 - $80.22 $1,565 - $2,005	25 New	25 $1,000
Q3 2019 Oct 30, 2019	SELL	$62.51 - $69.0 $8,126 - $8,970	-130 Closed	0 $0
Q2 2019 Aug 05, 2019	SELL	$61.87 - $69.38 $11,940 - $13,390	-193 Reduced 59.75%	130 $0
Q1 2019 May 06, 2019	SELL	$62.53 - $70.05 $2.13 Million - $2.39 Million	-34,070 Reduced 99.06%	323 $0
Q4 2018 Jan 28, 2019	SELL	$60.54 - $79.0 $123,017 - $160,528	-2,032 Reduced 5.58%	34,393 $2.15 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $548,428 - $607,210	7,694 Added 26.78%	36,425 $2.81 Million
Q2 2018 Jul 19, 2018	SELL	$64.88 - $75.68 $50,995 - $59,484	-786 Reduced 2.66%	28,731 $2.03 Million
Q1 2018 May 10, 2018	BUY	$72.84 - $88.8 $218,082 - $265,867	2,994 Added 11.29%	29,517 $2.23 Million
Q4 2017 Feb 02, 2018	BUY	$71.15 - $83.52 $45,678 - $53,619	642 Added 2.48%	26,523 $1.9 Million
Q3 2017 Nov 07, 2017	BUY	$72.11 - $85.47 $1.87 Million - $2.21 Million	25,881	25,881 $2.1 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Heritage Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Heritage Wealth Advisors with notifications on news.

Account

Heritage Wealth Advisors Gilead Sciences, Inc. Transaction History